Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY – Get Free Report)’s share price gapped down before the market opened on Wednesday . The stock had previously closed at $9.51, but opened at $8.5450. Ambu A/S shares last traded at $8.5450, with a volume of 151 shares changing hands.
Ambu A/S Trading Down 10.1%
The company has a debt-to-equity ratio of 0.08, a current ratio of 2.92 and a quick ratio of 1.73. The stock’s 50-day moving average is $10.12 and its two-hundred day moving average is $11.73. The stock has a market cap of $2.01 billion, a P/E ratio of 30.52 and a beta of 0.98.
Ambu A/S (OTCMKTS:AMBBY – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $0.07 earnings per share (EPS) for the quarter. The company had revenue of $246.39 million for the quarter. Ambu A/S had a net margin of 7.81% and a return on equity of 8.03%.
Ambu A/S Company Profile
Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.
Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.
Read More
- Five stocks we like better than Ambu A/S
- Dividend Increases: From Over 10% Yields to Over 10% Dividend Growth
- From Quantum to Clothing: Insider Trades Hit 3 Big Names
- ASML’s Chip Dominance Runs Into New Silicon Boundaries
- Why These South Korea-Focused ETFs Have More Than Doubled in 2026
Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.
